FDA Drug/Biologics Approval BLA 761055 S-007, DUPILUMAB

FDA Drug/Biologics Approval BLA 761055 S-007, DUPILUMAB

Regular price $49.00 USD
Regular price Sale price $49.00 USD
Sale Sold out
BLA 761055 S-007
Company: REGENERON PHARMACEUTICALS
Drug Name: DUPIXENT
Active Ingredients: DUPILUMAB
Strength: 150MG/ML
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 03/28/2017
Marketing Status: Prescription
Submission Classification: ORIG-1
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details